Skip to content

Efficacy of Phadiatop and skin prick test to detect inhalant allergen sensitization in children with frequent rhiniti

Efficacy of Phadiatop and skin prick test to detect inhalant allergen sensitization in children with frequent rhinitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20190215002
Enrollment
140
Registered
2019-02-15
Start date
2017-11-11
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

efficacy of Phadiatop

Interventions

comparison of the efficacy between Phadiatop and skin prick test which using nasal provocation test as gold standard diagnosis in patients with frequent rhinitis
Experimental Other
Phadiatop®

Sponsors

none
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 18 Years

Inclusion criteria

Inclusion criteria: Children age 5-18 years old who had frequent rhinitis in the past year **Definition: frequent rhinitis defined as rhinitis more than 6 times per year, and nasal symptoms (sneezing, itching, nasal obstruction, rhinorrhea) occur during two or more consecutive days for more than 1 h on most days

Exclusion criteria

Exclusion criteria: Children who had underlying chronic disease: liver disease, kidney disease, GI disease, autoimmune disease and uncontrolled asthma Children who denied for the blood test Children who could not perform skin prick test Children do not consent for the study

Design outcomes

Primary

MeasureTime frame
Efficacy of Phadiatop and skin prick test to detect inhalant allergen sensitization in children wi after enrollment diagnostic study

Secondary

MeasureTime frame
none none none

Countries

Thailand

Contacts

Public ContactSasiwimon Traiyan

Allergy and Immunology Division, Pediatric Department, Ramathibodi hospital

sasiwimon.tra@gmail.com+6685958216/8

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026